Abstract
Objective
The aim of this study is to evaluate if it is necessary to remove all the radioactive sentinel lymph nodes (SLNs) not seen on lymphoscintigraphy in order to accurately stage breast cancer patients.
Material and methods
From March 1999 to March 2006, SLN biopsy was performed in 461 patients. All patients were only injected with radioisotope. Lymphoscintigraphy was performed in all the patients. The mean number of SLNs removed was 2.1 (range 1–15).
Results
The SLN was positive in 133 patients (28.8%). Lymphoscintigraphy accurately predicted the number of SLNs identified intraoperatively in 243 patients (52.7%). In 175 patients (37.9%) there were more SLNs identified intraoperatively than were seen on lymphoscintigraphy. In 11 (6.2%) of these 175 patients, additional SLNs identified intraoperatively harboured metastasis. Type of injection, need for a second injection, tumour location and age were not identified as statistically significantly associated with additional positive SLNs identified intraoperatively and not seen on lymphoscintigraphy.
Conclusions
Lymphoscintigraphy does not accurately predict the number of SLNs identified intraoperatively, this number being underestimated. Surgeons should remove all radioactive SLNs to improve the detection of positive SLNs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Giuliano AE, Jones RC, Brennan M et al (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345–2350
Krag DN, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer — a multicenter validation study. N Engl J Med 339:941–946
Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864–1867
Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822
McMasters KM, Wong SL, Tuttle TM et al (2000) Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 231:724–731
Kawase K, Gayed IW, Hunt KK et al (2006) Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel node biopsy for breast cancer. J Am Coll Surg 203:64–72
Teal CB, Slocum JP, Akin EA et al (2005) Correlation of lymphoscintigraphy with the number of sentinel lymph nodes identified intraoperatively in patients with breast cancer. Am J Surg 190:567–569
Sutton R, Kollias J, Prasad V et al (2002) Same day lymphoscintigraphy and sentinel node biopsy for early breast cancer. ANZ J Surg 72:542–546
Newman LA (2004) Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique. J Am Coll Surg 199:804–816
Upponi SS, McIntosh SA, Wishart GC et al (2002) Sentinel lymph node biopsy in breast cancer — is lymphoscintigraphy really necessary? Eur J Surg Oncol 28:479–480
Wang L, Yu J, Wang Y et al (2007) Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer. Ann Surg Oncol 14:2215–2220
Kern KA (2002) Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and Technetium 99m sulphur colloid. J Am Coll Surg 195:467–475
Rodier JF, Velten M, Wilt M et al (2007) Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE Trial. J Clin Oncol 25:3664–3669
Doting MHE, Jansen L, Nieweg OE et al (2000) Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer 88:2546–2552
Lin KM, Patel TH, Ray A et al (2004) Intradermal radioisotope injection is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg 199:561–566
Klimberg VS, Rubio IT, Henry R et al (1999) Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 229:860–865
Chapgar A, Martin RC, Chao C et al (2004) Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 139:614–620
McMasters KM, Wong SL, Martin RCG et al (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg 233:676–687
Tuttle TM, Colbert M, Christensen R et al (2002) Subareolar injection of 99mTc facilitates sentinel lymph node identification. Ann Surg Oncol 9:77–81
Leikola JP, Leppanen EA, von Smitten KA et al (2006) A second radioisotope injection enhances intraoperative sentinel node identification in breast cancer patients without visualized nodes on preoperative lymphoscintigraphy. Acta Radiol 47:760–763
Shoher A, Diwan A, The BS et al (2006) Lymphoscintigraphy does not enhance sentinel node identification or alter management of patients with early breast cancer. Curr Surg 63:207–212
Marchal F, Rauch P, Morel O et al (2006) Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes. World J Surg 30:55–62
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rubio, I., Pedreira, F., Roca, I. et al. Removal of all radioactive sentinel nodes in breast cancer improves the detection of positive sentinel nodes. Clin Transl Oncol 10, 347–350 (2008). https://doi.org/10.1007/s12094-008-0210-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0210-0